SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc is seeing intense community engagement as investors gear up for a high-stakes earnings report and guidance update, with bullish sentiment fueled by recent defense contract wins and significant short interest. Traders are closely monitoring the technical struggle around the $10 level, debating the potential for a short-squeeze setup against the backdrop of broader sector volatility.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is experiencing high volatility as investors weigh aggressive AI infrastructure growth against valuation concerns and upcoming share lockup expirations. The community remains deeply divided, with some betting on a long-term breakout driven by recent strategic partnerships, while others heavily short the stock, citing bloated market caps and disappointing earnings results.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as the stock faces downward pressure following a recent analyst downgrade and investor concerns over the company's China market turnaround strategy. The community remains deeply divided, with many debating whether the current price represents a long-term value opportunity or a persistent value trap amidst intensifying competition.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is trending as investors weigh strong AI networking demand and record product orders against cautious sentiment surrounding headcount reductions and competitive pressures. The community remains divided, with many highlighting the stock as an undervalued AI infrastructure play poised for future growth, while others express skepticism regarding its ability to maintain margins and market share against rapidly evolving tech peers.

Securitize Corp. is a financial technology company, which engages in the provision of regulated infrastructure for the issuance, management, trading, and administration of tokenized real-world assets (RWAs). The company was founded on October 17, 2025 and is headquartered in Miami, FL.

Securitize Corp.

Securitize Corp. is facing significant volatility following its recent SPAC merger, with community sentiment deeply divided between long-term investors betting on the future of real-world asset tokenization and skeptical traders highlighting poor earnings and ongoing patent litigation. While the company's partnerships with major institutional players provide a bullish foundation, the stock is currently struggling under the weight of post-SPAC selling pressure and investor frustration over recent performance.

Investment Managers Series Trust II - Tradr 2X Short NBIS Daily ETF

Tradr 2X Short NBIS Daily ETF

The NBIZ leveraged ETF is experiencing intense volatility and community debate as traders grapple with significant price decay following its inverse tracking of Nebius. Investors are actively discussing the risks of holding the instrument through earnings and high-beta market swings, often highlighting the technical challenges of managing a 2X daily inverse product against a volatile underlying AI stock.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing high community engagement driven by strong quarterly revenue growth and increased revenue guidance, alongside active speculation regarding upcoming government contracts and partnerships. Investors are closely monitoring the company's progress in quantum hardware milestones while debating the impact of ongoing research costs on short-term price volatility.

Cheesecake Factory, Inc. engages in the operation of restaurant chains. It operates through the following segments: The Cheesecake Factory Restaurants, North Italia, Other FRC, and Other. The Cheesecake Factory Restaurants segment offers appetizers, pizza, seafood, steaks, chicken, burgers, small plates, pastas, salads, sandwiches and omelettes, and a selection of gluten-free items. The North Italia segment specializes in Italian cuisine. The Other FRC segment includes brands acquired from Fox Restaurant Concepts. The Other segment consists of the Flower Child brand, along with other businesses. The company was founded by David M. Overton, Oscar Overton, and Evelyn Overton in 1972 and is headquartered in Calabasas Hills, CA.

Cheesecake Factory Inc. (The)

Cheesecake Factory Inc.

Cheesecake Factory is trending as retail investors react to a powerful, extended rally that has pushed the stock to record highs, sparking intense debate between long-term bulls and those concerned about extreme technical overextension. While some community members point to strong operational execution and expansion of concepts like North Italia as justification for the move, others are calling for a pullback due to high RSI levels and aggressive insider selling.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to a negative opinion from the EMA's CHMP regarding the marketing authorization for YARTEMLEA in Europe, though the community remains heavily focused on the stock's long-term valuation potential driven by the U.S. commercial launch and upcoming J-code and NTAP catalysts. Shareholders are actively debating the company's prospects for a successful regulatory appeal, recent debt reduction strategies, and the potential for a future acquisition by a larger pharmaceutical partner.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is experiencing significant market interest driven by its expanding oncology and cell therapy pipeline, bolstered by key acquisitions and positive pipeline momentum. Investors are actively tracking institutional accumulation and technical strength as the company advances its diverse portfolio in HIV, oncology, and autoimmune treatments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


affordpilln

affordpill